News brief
On 2025/8/11, Forbes reported that biotechnology company Tahoe Therapeutics had raised USD 30 million at a USD 120 million valuation, bringing total funding to USD 42 million, with investment from Amplify Partners. It uses living-cell AI models to find new cancer treatments.
Connected profiles
Sources · 1Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
- www.forbes.com ↗Published Aug 11, 2025
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
2025年8月11日，据Forbes报道，生物技术公司Tahoe Therapeutics完成3000万美元融资，估值达1.2亿美元，累计融资4200万美元，由Amplify Partners投资。该公司用活细胞AI模型寻找新癌症治疗方法。